LEAPS influenza A virus vaccine-H1N1 in patients with influenza A virus H1N1 subtype
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2009
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- 06 Nov 2009 Status changed from planning to recruiting. CEL SCI announced in a media release that the Institutional Review Board of The Johns Hopkins University School of Medicine (Johns Hopkins) has given clearance for this clinical study to proceed.
- 22 Sep 2009 New trial record.
- 16 Sep 2009 US FDA approval for trial initiation.